PP

Punnami Pasham

Active Director Director DIN 09448332
DIN 09448332 First appointment Jan 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Punnami Pasham

Data last updated:

Punnami Pasham is a Director at Biovico Healthcare Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09448332
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 19 Jan 2022
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biovico Healthcare Private Limited U85320TG2019PTC137169
Director19 Jan 20222019Active

Directorship timeline

Open interactive timeline →
Biovico Healthcare Private Limited
Premium access

Shareholding and investment profile for Punnami Pasham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Punnami Pasham

Punnami Pasham currently holds 1 directorship: Biovico Healthcare Private Limited (Director, since 19 Jan 2022).

Punnami Pasham was first appointed on 19 Jan 2022 as Director at Biovico Healthcare Private Limited.

The current boards of Punnami Pasham's companies include Bhanukiran Kondukoori (Biovico Healthcare Private Limited), Durga Padmini Priya Vusirikayala (Biovico Healthcare Private Limited), Ganga Devi Telukutla (Biovico Healthcare Private Limited), Venkat Laxmi Putti (Biovico Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available